13F Insight
DOSSIER · 13F-HR · Q2 2026

Parkman Healthcare Partners LLC

$977M in tracked AUM across 77 positions as of Q2 2026.

PH
CIK 0001777015 · last filed Jun 30, 2026
Total AUM
$977M
as of Q2 2026
Holdings
77
—
positions
Whale Score
56
56
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Parkman Healthcare Partners LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
MBX
MBX BIOSCIENCES INC
$44M800K4.5%02
LLY
ELI LILLY & CO
$42M35K4.3%03
CVS
CVS HEALTH CORP
$41M392K4.1%04
DXCM
DEXCOM INC
$36M535K3.7%05
PTCT
PTC THERAPEUTICS INC
$36M436K3.6%06
RCUS
ARCUS BIOSCIENCES INC
$28M919K2.9%07
GPCR
STRUCTURE THERAPEUTICS INC
$26M486K2.7%08
VRDN
VIRIDIAN THERAPEUTICS INC
$25M1.4M2.6%09
AGIO
AGIOS PHARMACEUTICALS INC
$25M669K2.5%10
INBX
INHIBRX BIOSCIENCES INC
$24M257K2.5%

Filing history

2026Q2Jun 30
$977M▲ 0.7%
77 positionsView →2026Q1Mar 31
$970M▼ 7.7%
90 positionsView →2025Q4Dec 31
$1.1B▲ 72.7%
100 positionsView →2025Q3Sep 30
$608M▼ 30.1%
60 positionsView →2025Q2Jun 30
$870M▲ 76.2%
88 positionsLocked2025Q1Mar 31
$494M▼ 34.2%
61 positionsLocked2024Q4Dec 31
$751M▼ 4.2%
89 positionsLocked2024Q3Sep 30
$783M▲ 4.9%
93 positionsLocked2024Q2Jun 30
$747M▼ 8.4%
90 positionsLocked2024Q1Mar 31
$815M▲ 14.8%
99 positionsLocked2023Q4Dec 31
$710M▲ 30.1%
89 positionsLocked2023Q3Sep 30
$546M▼ 5.4%
102 positionsLocked
Showing 12 of 27